$27 Million Settlement with Precision Toxicology

Whistleblower Partners represents whistleblowers who contributed to the government’s recovery of $27 million from Precision Toxicology under the False Claims Act for allegedly overcharging Medicaid and Medicare for urine drug testing. As the addiction crisis unfortunately continues to spread, urine drug testing is a regular component of addiction centers and other recovery options. The government will generally only pay for these tests if they are narrowly tailored to the individual’s specific needs. Precision allegedly did not narrowly tailor its drug panels, instead providing a standard overly inclusive panel for all patients. Precision furthermore is alleged to have provided free gifts to doctors in exchange for their business, in violation of the Anti-Kickback Statute. Read the Department of Justice press release here.